“…The hearing preservation rate after SRS for VSs has been reported to be 50%-78%. 10,17,18,25,26,33,37,43 Several factors have been suggested to affect hearing preservation, including tumor volume, pretreatment hearing status, age, cochlear dose, brainstem cochlear nucleus dose, and marginal dose ≤ 13 Gy. 8,9,11,21,26,33,38,43,46 Similarly, we found that patients with Grade I hearing fared better regarding hearing preservation.…”